Citations

Mayo Clinic

Showing 10 of 108551 citations.

Faculty Opinions recommendation of Novel intragastric trocar placed by PEG technique permits endolumenal use of rigid instruments to simplify complex endoscopic procedures.
Song, Louis M. Wong Kee

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | April 28, 2016 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.726308870.793517356 Get It

Elementary School–Based Obesity Intervention Using an Educational Curriculum
Lynch, Brian , Gentile, Natalie, Maxson, Julie, Quigg, Stephanie, Swenson, L, Kaufman, Tara K. , Lynch, Brian A, Swenson, Laura, Kaufman, Tara

Journal of Primary Care & Community Health | April 28, 2016 | Volume: 7 | Issue: 4 | Pages: 265-271

10.1177/2150131916644888 | PMID 27121724 Get It

Background: Pediatric obesity is a significant public health problem with a prevalence of 16.9% among US children. School-based obesity interventions show promise for reducing adiposity in elementary age children. This pilot study evaluated the impact of the Let’s Go! 5-2-1-0 pediatric obesity intervention program in an elementary school setting. Methods: This was a cluster randomized controlled field trial comprising 8 classrooms of second- and third-grade children. The impact of implementation of a standardized 5-2-1-0 curriculum was evaluated in the classrooms by looking at health behavior (self-reported fruit and vegetable and sugar-containing beverage intake, and screen time), physical activity (steps measured by pedometer), and body mass index (BMI). Half of the classrooms were given 5-2-1-0 teaching over a 4-month period. Results: There was no statistical difference in improvement of healthy habits, BMI, or physical activity in the intervention group compared with the control group. Conclusions: The 5-2-1-0 intervention used in this study was feasible. There was no significant change in healthy habits, likely due to the small number of participants in the study. The intervention and control sites were in different classrooms and there could be factors such as teacher enthusiasm, socioeconomic factors, and individual traits affecting habits. Future studies could use pre- and post-intervention quizzes to assess healthy habits knowledge retention, involving the environments the child participates in outside of school, using research-grade pedometers or accelerometers for measuring activity data collection, and recruiting larger samples to ensure adequate statistical power.
Association between mitochondrial DNA haplogroup and myelodysplastic syndromes
Poynter, Jenny N. , Richardson, Michaela , Langer, Erica , Hooten, Anthony J. , Roesler, Michelle A. , Hirsch, Betsy , Cioc, Adina, Warlick, Erica D. , Ross, Julie A. , Nguyen, Phuong L., Nguyen, Phuong

Genes, Chromosomes and Cancer | April 28, 2016 | Volume: 55 | Issue: 9 | Pages: 688-693

10.1002/gcc.22370 | PMID 27121678 Get It

Polymorphisms in mitochondrial DNA (mtDNA) are used to group individuals into haplogroups reflecting human global migration and are associated with multiple diseases, including cancer. Here, we evaluate the association between mtDNA haplogroup and risk of myelodysplastic syndromes (MDS). Cases were identified by the Minnesota Cancer Surveillance System. Controls were identified through the Minnesota State driver's license/identification card list. Because haplogroup frequencies vary by race and ethnicity, we restricted analyses to non‐Hispanic whites. We genotyped 15 mtSNPs that capture common European mitochondrial haplogroup variation. We used SAS v.9.3 (SAS Institute, Cary, NC) to calculate odds ratios (OR) and 95% confidence intervals (CI) overall and stratified by MDS subtype and IPSS‐R risk category. We were able to classify 215 cases with confirmed MDS and 522 controls into one of the 11 common European haplogroups. Due to small sample sizes in some subgroups, we combined mt haplogroups into larger bins based on the haplogroup evolutionary tree, including HV (H + V), JT (J + T), IWX (I + W + X), UK (U + K), and Z for comparisons of cases and controls. Using haplogroup HV as the reference group, we found a statistically significant association between haplogroup JT and MDS (OR = 0.58, 95% CI 0.36, 0.92, P = 0.02). No statistically significant heterogeneity was observed in subgroup analyses. In this population‐based study of MDS, we observed an association between mtDNA haplogroup JT and risk of MDS. While previously published studies provide biological plausibility for the observed association, further studies of the relationship between mtDNA variation and MDS are warranted in larger sample sizes. © 2016 Wiley Periodicals, Inc.
Topiramate for Treatment in Patients With Migraine and Epilepsy
Spritzer, Scott, Bravo, Thomas P., Drazkowski, Joseph F., Spritzer, Scott D

Headache: The Journal of Head and Face Pain | April 28, 2016 | Volume: 56 | Issue: 6 | Pages: 1081-1085

10.1111/head.12826 | PMID 27122361 Get It

Background Antiepileptic drugs (AED) are often considered first line for monotherapy in treatment of patients with migraines, and also those with comorbid migraine and epilepsy. Topiramate, a newer generation AED, has broad mechanism of action and evidence of benefit in patients with either episodic or chronic migraine along with epilepsy, both generalized and focal. Methods Our goal is to review the relevant mechanisms of action along with any supportive evidence published to date on the use of topiramate (TPM) in patients with both migraine headache and epilepsy. Conclusions There has been very little published to date on the use of TPM in patients diagnosed with both disorders. Despite this, TPM has been adopted as first line therapy in this patient population. Future studies investigating the effectiveness of this treatment strategy are warranted in order to determine the most effective use of this medication in patients diagnosed with migraine headaches and epilepsy.
Differential effects in CGRPergic, nitrergic, and VIPergic myenteric innervation in diabetic rats supplemented with 2% L-glutamine
Pereira, Renata Virginia Fernandes, Neto, Marcílio Hübner de Miranda , Zanoni, Jacqueline Nelisis , Linden, David R.

Anais da Academia Brasileira de Ciências | April 27, 2016 | Volume: 88 | Issue: suppl 1 | Pages: 609-622

10.1590/0001-3765201620150228 | PMID 27142540 Get It

ABSTRACT The objective of this study was to investigate the effects of 2% L-glutamine supplementation on myenteric innervation in the ileum of diabetic rats, grouped as follows: normoglycemic (N); normoglycemic supplemented with L-glutamine (NG); diabetic (D); and diabetic supplemented with L-glutamine (DG). The ileums were subjected to immunohistochemical techniques to localize neurons immunoreactive to HuC/D protein (HuC/D-IR) and neuronal nitric oxide synthase enzyme (nNOS-IR) and to analyze varicosities immunoreactive to vasoactive intestinal polypeptide (VIP-IR) and calcitonin gene-related peptide (CGRP-IR). L-Glutamine in the DG group (i) prevented the increase in the cell body area of nNOS-IR neurons, (ii) prevented the increase in the area of VIP-IR varicosities, (iii) did not prevent the loss of HuC/D-IR and nNOS-IR neurons per ganglion, and (iv) reduced the size of CGRP-IR varicosities. L-Glutamine in the NG group reduced (i) the number of HuC/D-IR and nNOS-IR neurons per ganglion, (ii) the cell body area of nNOS-IR neurons, and (iii) the size of VIP-IR and CGRP-IR varicosities. 2% L-glutamine supplementation exerted differential neuroprotective effects in experimental diabetes neuropathy that depended on the type of neurotransmitter analyzed. However, the effects of this dose of L-glutamine on normoglycemic animals suggests there are additional actions of this beyond its antioxidant capacity.
The Lipid Hypothesis in Calcific Aortic Valve Disease
Rajamannan, Nalini M. , Moura, Luís M. , Moura, Luis

Arteriosclerosis, Thrombosis, and Vascular Biology | April 27, 2016 | Volume: 36 | Issue: 5 | Pages: 774-776

10.1161/atvbaha.116.307435 | PMID 27122627 Get It

Vitelliform dystrophies: Prevalence in Olmsted County, Minnesota, United States
Pulido, José S. , Marmorstein, Alan D. , Dalvin, Lauren A. , Marmorstein, Alan D

Ophthalmic Genetics | April 27, 2016 | Volume: 38 | Issue: 2 | Pages: 143-147

10.1080/13816810.2016.1175645 | PMID 27120116 Get It

JNK2 downregulation promotes tumorigenesis and chemoresistance by decreasing p53 stability in bladder cancer
Pan, Chun-Wu, Liu, Hailong , Qian, Chenchen , Wang, Liguo , Qi, Jun , Zhao, Yu , Wang, Liguo

Oncotarget | April 27, 2016 | Volume: 7 | Issue: 23 | Pages: 35119-35131

10.18632/oncotarget.9046 | PMID 27147566 Get It

Serologic microbial associated markers can predict Crohn's disease behaviour years before disease diagnosis
Choung, Rok Seon , Princen, Fred, Stockfisch, Thomas P. , Torres, Joana , Maue, Alexander C., Porter, Chad K., Vroey, Bénédicte De, Singh, Sharat , Riddle, Mark S. , Team, the PREDICTS Study, Porter, Chad K. , Leon, F., Murray, Joseph A. , Colombel, Jean‐Frédéric , Team, the PREDICTS Study, Torres, Joana , Choung, Rok Seon

Alimentary Pharmacology & Therapeutics | April 27, 2016 | Volume: 43 | Issue: 12 | Pages: 1300-1310

10.1111/apt.13641 | PMID 27117843 Get It

Summary Background Patients with Crohn's disease ( CD ) have serologic responses to various microbial antigens. Serologic markers are associated with aggressive forms of disease and can be detected before onset of symptoms. Their utility in pre‐clinical disease or prediction of complicated disease course before diagnosis is unclear. Aim To evaluate the pattern of serologic anti‐microbial antibodies long prior to diagnosis and the subsequent risk of complicated Crohn's disease at diagnosis. Methods Sera from 100 US military personnel with Crohn's disease were obtained from the Department of Defense Serum Repository. For each patient, four samples were obtained at different time points before and around diagnosis, and were tested for 6 microbiota‐directed antibodies ( ASCA ‐IgA, ASCA ‐IgG, anti‐OmpC, anti‐ CB ir1, anti‐A4‐Fla2 and anti‐FlaX). Associations between the presence and accumulation of Crohn's disease anti‐microbial antibodies before diagnosis and with the later development of complications were evaluated. Results Overall, 65 patients were positive for at least one Crohn's disease associated anti‐microbial antibody in the earliest available sample, at a median of 6 years before Crohn's disease diagnosis (interquartile range, 5.6–8.2). The number of positive anti‐microbial antibodies increased up to the time of Crohn's disease diagnosis. Complicated disease developed around the time of diagnosis in 24 patients. The proportion of positive antimicrobial antibodies before diagnosis was higher in patients with complicated vs. noncomplicated Crohn's disease. There was an inverse relationship between the time to first complication and the magnitude of serologic response before diagnosis. Conclusion The presence and accumulation of circulating anti‐microbial antibodies years before Crohn's disease diagnosis was associated with complicated Crohn's disease at or shortly after diagnosis.
Impact of the Pharmacy Practice Model Initiative on Clinical Pharmacy Specialist Practice
Jacobi, Judith , Ray, Shaunta’ M., Danelich, Ilya , Ashley, Elizabeth Dodds , Guharoy, Roy , Militello, Michael, O’Donnell, Ed, Sam, Teena , Crist, Stephanie M., Smidt, Danielle, O'Donnell, Paul , Eckel, Stephen F

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy | April 27, 2016 | Volume: 36 | Issue: 5 | Pages: No page available

10.1002/phar.1745 | PMID 27118546 Get It

This paper describes the goals of the American Society of Health‐System Pharmacists' Pharmacy Practice Model Initiative (PPMI) and its recommendations for health‐system pharmacy practice transformation to meet future patient care needs and elevate the role of pharmacists as patient care providers. PPMI envisions a future in which pharmacists have greater responsibility for medication‐related outcomes and technicians assume greater responsibility for product‐related activities. Although the PPMI recommendations have elevated the level of practice in many settings, they also potentially affect existing clinical pharmacists, in general, and clinical pharmacy specialists, in particular. Moreover, although more consistent patient care can be achieved with an expanded team of pharmacist providers, the role of clinical pharmacy specialists must not be diminished, especially in the care of complex patients and populations. Specialist practitioners with advanced training and credentials must be available to model and train pharmacists in generalist positions, residents, and students. Indeed, specialist practitioners are often the innovators and practice leaders. Negotiation between hospitals and pharmacy schools is needed to ensure a continuing role for academic clinical pharmacists and their contributions as educators and researchers. Lessons can be applied from disciplines such as nursing and medicine, which have developed new models of care involving effective collaboration between generalists and specialists. Several different pharmacy practice models have been described to meet the PPMI goals, based on available personnel and local goals. Studies measuring the impact of these new practice models are needed.